KNUDSON MARK B 4

Accession 0001181431-12-052298

CIK 0001371217other

Filed

Sep 27, 8:00 PM ET

Accepted

Sep 28, 5:16 PM ET

Size

24.9 KB

Accession

0001181431-12-052298

Form 4

Period: 2012-09-27

DirectorChrmn, Pres & CEO

Transactions

Award
Stock Option (right to buy)
2012-09-27+1,292,225→ 1,292,225 total
Exercise: $3.35From: 2012-08-10Exp: 2022-07-10→ Common Stock (1,292,225 underlying)

Holdings

Stock Option (right to buy)
Exercise: $1.90From: 2010-10-29Exp: 2017-10-29→ Common Stock (50,472 underlying)
50,472
Stock Option (right to buy)
Exercise: $2.58From: 2011-03-16Exp: 2021-02-16→ Common Stock (350,000 underlying)
350,000
Common Stock
(indirect: By Trust)
1,382
Stock Option (right to buy)
Exercise: $1.90From: 2010-10-29Exp: 2017-10-29→ Common Stock (33,432 underlying)
33,432
Stock Option (right to buy)
Exercise: $1.90From: 2010-10-29Exp: 2017-10-29→ Common Stock (25,902 underlying)
25,902
Warrant (Common Stock)
Exercise: $2.19→ Common Stock (25,000 underlying)
25,000
Common Stock
(indirect: By Partnership)
3,215
Stock Option (right to buy)
Exercise: $2.76From: 2004-08-16Exp: 2014-08-16→ Common Stock (11,575 underlying)
11,575
Stock Option (right to buy)
Exercise: $1.90From: 2012-01-14Exp: 2021-12-14→ Common Stock (200,000 underlying)
200,000
Common Stock
(indirect: By Trust)
57,571
Stock Option (right to buy)
Exercise: $1.90From: 2010-10-29Exp: 2017-10-29→ Common Stock (44,131 underlying)
44,131
Stock Option (right to buy)
Exercise: $2.76From: 2007-04-20Exp: 2016-04-20→ Common Stock (6,776 underlying)
6,776
Warrant (Right to Buy)
(indirect: By Trust)
Exercise: $8.28From: 2009-08-24Exp: 2013-02-24→ Common Stock (5,498 underlying)
5,498
Stock Option (right to buy)
Exercise: $3.78From: 2009-11-18Exp: 2019-11-18→ Common Stock (20,833 underlying)
20,833
Stock Option (right to buy)
Exercise: $2.76Exp: 2015-04-27→ Common Stock (7,915 underlying)
7,915

Footnotes (9)

[F1]32,968 shares vest immediately, of the remaining shares 25% vest on the first anniversary of the date of grant and thereafter at 1/36th per month for 36 months, beginning the date shown.
[F2]Currently 100% vested in accordance with achievement of milestone vesting terms.
[F3]Vests 25% on the first anniversary of the date of grant and 1/36th per month for 36 months thereafter, beginning the date shown.
[F4]25% vests immediately and the remaining 75% vests on 11/15/2010; 100% of unvested shares become vested upon change in control.
[F5]Options vest 33% on date noted and thereafter at 1/24th per month.
[F6]Warrant becomes exercisable 181 days from the date of issuance at close of offering.
[F7]Warrant expires five years from the date it becomes exercisable.
[F8]Vests in increments of 1/48th per month, beginning the date shown.
[F9]The exercise price is the closing price on July 10, 2012, the date the board authorized the grants subject to stockholder approval of the increase in the number of shares available for awards under the stock incentive plan, which was obtained on September 27, 2012.

Documents

1 file

EnteroMedics Inc

CIK 0001371217

Entity typeother